The biotech industry is aggressively moving from the development arena into manufacturing and production. To date, the focus has been on “proof” and “validation.” Much progress is being made in expanding research efforts to be applied to general/popular interest arenas. Wolfe Engineering assists leading biotech companies in migrating approved and sanctioned research efforts into productive, cost effective manufacturing operations. 

Based on industry momentum and potential partnership agreements currently in negotiation, Wolfe’s senior leadership team conservatively forecasts the biotech market will represent 10 percent of company revenue by Q4 2004 and will grow by five percent each year through 2007.